Beruflich Dokumente
Kultur Dokumente
Staphylococcus, pneumococcus, legionella, syphilis, mumps, varicella, hepatitis B and C, echovirus, Epstein barr virus, toxoplasmosis, malaria, schistosomiasis, trichinosis
epidemiology
Worldwide, Berger disease is the most common
cause of GN the incidence of PSGN has fallen in most Western countries. PSGN remains much more common in regions such as Africa, the Caribbean, India, Pakistan, Malaysia, Papua New Guinea, and South America the incidence of acute GN in children aged 3-16 years was 15.5 cases per year, with a male-to-female ratio of 1.1:1
etiology
Group A beta hemolytic streptococcus PSGN usually develops 1-3 weeks after acute infection with specific nephritogenic strains of group A beta-hemolytic streptococcus Only few strains of streptococci are nephritogenic, eg. Type 4 and 12 causing pharyngitis and type 49 causing pyoderma. The incidence of GN is approximately 5-10% in persons with pharyngitis and 25% in those with skin infections.
pathogenesis
pathology
Histopathology- glomeruli appear enlarged and
shows diffuse mesangial cell proliferation with invasion of acute inflammatory cells Immunofluorescence- C3 and IgG deposition on glomerular BM and in the mesangium. Electron microscopy- electron dense deposits or hump like deposits of immunocomplexes seen on epithelial side of GBM Changes usually restricted to mesangium and endothilium with minimal epithilial proliferation
PSGN - hypercellular glomerulus with proliferating endothelial and mesangial cells, and neutrophil infiltration.
Clinical presentation
infection.
Clinical presentation
3 phase sequence: infection - interval - nephritic syndrome The severity of renal involvement varies from asymptomatic
Hematuria(cola coloured) Oliguria( Reduced GFR) Oedema (Salt and water retention) periorbital puffiness and pedal edema Hypertension
Diagnosis
Urinalysis
Rbc Frequently in association with rbc casts Mild proteinuria Polymorp leukocytes
pharyngeal infection
anti-deoxyribonuclease (DNase) B level after cutaneous
infection.
presence of acute renal failure, nephrotic syndrome, absence of evidence of streptococcal infection, or normal complement levels. In addition, renal biopsy is considered when hematuria and proteinuria, diminished renal function, and/or a low C3 level persist more than 2 mo after onset
treatment
Focused on treating acute effects of renal insufficiency and
hypertension
Restriction of salt and fluid Antibiotics (ex. Penicillin), for streptococcal bacteria- to limit
spread of organism
Blood pressure medications
prognosis
Usually mild disease recovery typically within weeks ( 95% ) 1 week: onset of diuresis
Possible complications
Congestive heart failure pulmonary edema Hyperkalemia High blood pressure (hypertension) Acute renal failure Chronic glomerulonephritis
IgA nephropathy
IgA nephropathy
Pathogenesis Focal and segmental proliferative glomerulonephritis with mesangial deposit of polymeric IgA
Etiology Unknown May be a result of an exaggerated bone marrow and tonsillar IgA immune response to viral or other antigens
Proteinuriaoften, but severity < nephrotic, often <1g/24h Hypertensionmild to moderate Normal serum C3 Serum IgA levels have no diagnostic value because they are
kidney damage in most children, progressive disease develops in 2030% of children at 1520 yr after disease onset.
diminished renal function, and heavy or prolonged proteinuria. A worse prognosis is suggested by histologic evidence of diffuse mesangial proliferation, extensive glomerular crescents, glomerulosclerosis, and tubulointerstitial changes, including inflammation and fibrosis.
treatment
Primary treatment is proper blood pressure control Fish oil, which contains anti-inflammatory omega-3
receptor antagonists are effective in reducing proteinuria and retarding the rate of renal progression when used as single agents or in combination. the rate of renal disease progression
abdominal pain, and glomerulonephritis HSP nephritis and IgA nephropathy demonstrate identical renal pathologic findings, but systemic findings are only seen in HSP nephritis
pathogenesis
The pathogenesis of HSP nephritis remains
unknown this disease appears to be mediated by the formation of immune complexes containing polymeric IgA1 within capillaries of the skin, intestines, and glomerulus.
appear 13 wk after an upper respiratory tract infection gross hematuria is seen in 2030% of cases patients may also present with isolated microscopic hematuria, hematuria and proteinuria. Renal manifestations of HSP nephritis occur up to 12 wk after the initial presentation of HSP
treatment
Symptomatic Some studies suggest that short courses of low-dose
prednisone initiated at diagnosis reduce the subsequent risk of developing any clinical signs of nephritis
loss of renal function, (usually a 50% decline in the glomerular filtration rate (GFR) within 3 months) with glomerular crescent formation seen in at least 50% or 75% of glomeruli seen on kidney biopsies.
Crescentic glomerulonephritis (PAS stain). Note the collapsed glomerular tufts and the crescent-shaped mass of proliferating cells and leukocytes internal to Bowman capsule
ANTI-GBM ANTIBODYMEDIATED RPGN 20% Goodpasture syndrome Idiopathic anti-GBM nephritis Membranous nephropathy with crescents RPGN ASSOCIATED WITH GRANULAR IMMUNE DEPOSITS 40% Postinfectious Poststreptococcal glomerulonephritis Bacterial endocarditis Shunt nephritis Visceral abscesses, other nonstreptococcal infections Noninfectious Systemic lupus erythematosus Henoch-Schnlein purpura Mixed cryoglobulinemia Solid tumors Primary Renal Disease Membranoproliferative glomerulonephritis IgA nephropathy Idiopathic immune-complex nephritis RPGN WITHOUT GLOMERULAR IMMUNE DEPOSITS 40% Vasculitis Polyarteritis Hypersensitivity vasculitis Wegener granulomatosis Idiopathic RPGN
Sign & symptoms The clinical picture is consistent with nephritic syndrome, although the degree of proteinuria may occasionally exceed 3 g/24 h, a range associated with nephrotic syndrome Diagnosis The presence of anti-Glomerular basement membrane (GBM) antibodies suggests type I RPGN;antinuclear antibodies (ANA) may support a diagnosis of systemic lupus erythematosus and type II RPGN; and type III and idiopathic RPGN are frequently associated with anti-neutrophil cytoplasmic antibodies (ANCA)-positive serum.
Treatment
Excellent therapeutic response using a combination of corticosteroids and cytotoxic therapy with cyclophosphamide often occurs in patients with systemic lupus erythematosus, IgA nephropathy, and Henoch-Schnlein purpura nephritis Plasmapheresis beneficial in patients with systemic vasculitides and Goodpasture syndrome
THANK YOU.
References
Nelson Textbook Of Paediatric 18th Ed. Kumar & Clarks Clinical Medicine 7th Ed. Ghais Essential Paediatric 7th Ed.
Emedicine.medscape.com